Chief Physician Radiooncology, Co-Head of Tumour Centre

Prof. Dr med. Wolfgang Harms

Co-Head of the Uro-oncology Centre
Deputy Head of Breast Centre
Deputy Head of Visceral Oncology Centre
Prof. Dr med.

Since 2007

Head of Radiooncology, Claraspital, Basel

2005

Associate Professor of Clinical Radiology and Radiotherapy at the University of Heidelberg
Hanns-Langendorff Prize of the German Society for Medical Radiation Protection and the Hanns-Langendorff Foundation
Intensive seminar on medical controlling
Seminar: Benchmarking at Heidelberg University Hospital

2004

Seminar: "DRG Benchmarking" - Practical application of the inter-company comparison at the hospital
Seminar: Risk Management
DRG management in radiation oncology

2004 - 2007

Elected to the scientific advisory board of the Southwest German Breast Centre - Heidelberg (SWBC)
Member of the Uterine Organ Commission of the Gynaecological Oncology Working Group

2003

Innovation Award of the German Society for Radiooncology (DEGRO)
Seminar: Leadership and Management
Seminar: Personnel and Organisation
Seminar: Behaviour and technology in meetings
Seminar: Labour law at university hospitals
Seminar: Medical law
Seminar: Work organisation - energy and time management for managers

2002

Habilitation and Venia legendi for the subject Clinical Radiology/Radiation Therapy
Seminar: Diagnosis Related Groups (DRG): Basics for the clinically active physician
Seminar: Recruitment interviews

2001

Seminar: Profitability, costs, financing

Memberships

SASRO Swiss Society for Radiation Oncology

DEGRO German Society for Radiooncology e.V.

ESTRO European Society for Therapeutic Radiology and Oncology

ASTRO American Society for Therapeutic Radiology and Oncology

DKG German Cancer Society

Pu­bli­ca­ti­ons

  • Appius H, Hafer J, Harms W, Bolli M, Buess: Reproducibility of the CROSS-Trial Results in the Multimodal Treatment of Esophageal Cancer in Daily Practice: A Single Centre Retrospective Observational Study. M. J Oncol. 8955720.
  • Appius H, Hafer J, Harms W, Bolli M, Buess: Reproducibility of the CROSS-Trial Results in the Multimodal Treatment of Esophageal Cancer in Daily Practice: A Single Centre Retrospective Observational Study. M. J Oncol. 8955720.
  • Krug D, Baumann R, Combs SE, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Strnad V, Budach W: Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). 33 Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward. 2021: Radiation Oncol. 197(4): 269-280.
  • Piroth MD, Krug D, Sedlmayer F, Duma MN, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Souchon R, Strnad V, Sauer R: Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Post-neoadjuvant treatment with capecitabine and trastuzumab emtansine in breast cancer patients - sequentially, or better simultaneously? 2021: Radiation Oncol. 197(1): 1-7.
  • Asadpour B, Harms W: Total neoadjuvant radiochemotherapy (TNT) enables organ preservation. 2021: Swiss Journal of Oncology 5: 12-16.
  • Strnad V, Krug D, Sedlmayer F, Piroth MD, Budach W, Baumann R, Feyer P, Duma MN, Haase W, Harms W, Hehr T, Fietkau R, Dunst J, Sauer R; Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). DEGRO practical guideline for partial-breast irradiation. Radiation Oncol. 2020 Sep;196(9):749-763. doi: 10.1007/s00066-020-01613-z. Epub 2020 Apr 29. PMID: 32350554; PMCID: PMC7449998.
  • Krug D, Baumann R, Budach W, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R. Commercially Available Gene Expression Assays as Predictive Tools for Adjuvant Radiotherapy? A Critical Review. Breast Care (Basel). 2020 Apr;15(2):118-126. doi: 10.1159/000505656. Epub 2020 Jan 24. PMID: 32398980; PMCID: PMC7204850.
  • Harms W, Asadpour B, Mosna-Firlejczyk K, Neppach K, Cescato-Wenger C, Siebert M, Zanetti Dällenbach R. Radiotherapy of breast cancer: long, short and ultra-short protocol. Leading Opinions Haematology and Oncology 07/2020
  • Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Röser A, Sedlmayer F, Souchon R, Wenz F, Sauer R; Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention. Strahlenther Onkol. 2019 Jan; 195(1): 1-12. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO).
  • Duma MN, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Piroth MD, Sedlmayer F, Souchon R, Sauer R; Heart-sparing radiotherapy techniques in breast cancer patients: a recommendation of the breast cancer expert panel of the German society of radiation oncology (DEGRO). Strahlenther Onkol. 2019 Oct; 195(10): 861-871.
  • Hehr T, Baumann R, Budach W, Duma MN, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Krug D, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R; Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer: Indication and technical considerations. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Radiation Oncology. 2019 Nov; 195(11): 949-963.
  • Piroth MD, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Krug D, Röser A, Sedlmayer F, Souchon R, Wenz F, Sauer R. Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention. Radiation Oncol. 2018 Oct 11.
  • Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R. Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO). Neoadjuvant chemotherapy for breast cancer-background for the indication of locoregional treatment. Radiation Oncol. 2018 Sep; 194(9): 797-805.
  • Krug D, Baumann R, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, Harms W, Hehr T, Piroth MD, Sedlmayer F, Souchon R, Wenz F, Sauer R. Individualisation of post-mastectomy radiotherapy and regional nodal irradiation based on treatment response after neoadjuvant chemotherapy for breast cancer: A systematic review. Radiation Oncol. 2018 Jul; 194(7): 607-618.

  • Grosser K., Schulte A., Harms W.: An Electronically Configurable Checklist Programme for Quality Control of RT Treatment Planning. Radiotherapy and Oncology; Volume 123, Supplement 1, 2017 May; S563

  • Herraiz Lablanca M., Paul S., Chiesa M., Grosser K., W. Harms: Evaluation of an Auto-segmentation Software for Definition of Organs at Risk in Radiotherapy. Radiotherapy and Oncology; Volume 123, Supplement 1, 2017 May; S554
  • Krug D., Baumann R., Budach W., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M., Sautter-Bihl M., Sedlmayer F., Souchon R., Wenz F., Sauer R.; Breast cancer expert panel of the German Society of Radiation Oncology (DEGRO): Current Controversies in Radiotherapy for Breast Cancer. Radiat Oncol. 2017 Jan 23; 12(1): 25
  • Harms, W., Budach, W., Dunst, J. et al: DEGRO practical guidelines for radiotherapy of breast cancer VI: therapy of locoregional breast cancer recurrences. Radiation Oncol 2016: 192: 199-208
  • Harms W., Geretschläger A., Cescato C., Buess M., Köberle D., Asadpour B.: Current Treatment of Isolated Locoregional Breast Cancer Recurrences. Breast Care (Basel). Aug 2015: 10(4): 265-71
  • Asadpour B., Harms W.: From adjuvant to neoadjuvant radio/radiochemotherapy: Multimodal therapy of rectal carcinoma. InFo Oncology & Haematology. 2015: 8: 1-6
  • Budach W., Matuschek C., Bölke E., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M.D., Sautter-Bihl M.L., Sedlmayer F., Souchon R., Wenz F., Sauer R.: Breast Cancer Expert Panel of German Society of Radiation Oncology (DEGRO). DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 2015: 191: 623-33
  • Rochet N., Lindel K., Katayama S., Schubert K., Herfarth K., Schneeweiss A., Sohn C., Harms W., Debus J.: Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer: four-year outcomes. Strahlenther Onkol. 2015: 191: 582-9
  • Sautter-Bihl M.L., Sedlmayer F., Budach W., Dunst J., Feyer P., Fietkau R., Haase W., Harms W., Piroth M. D., Souchon R., Wenz F., Sauer R. - Breast Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO): How nescience may obscure evidence. Radiother. Oncol. Oct 2014: 190(10): 861-3.
  • Rochet N, Sterzing F, Jensen A, Dinkel J, Herfarth K, Schubert K, Eichbaum M, Schneeweiss A, Sohn C, Debus J, Harms W.: intensity-modulated whole-abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study. Int J Radiat Oncol Biol Phys 2009 in press.
  • Hauswald H, Rochet N, Becker H, Stoiber E, Debus J, Harms W.: Treatment of Recurrent Bronchial Carcinoma: The Role of High-Dose-Rate Endoluminal Brachytherapy (HDREB). Int J Radiat Oncol Biol Phys 2009 in press.
  • Sautter-Bihl ML, Souchon R, Budach W, Sedlmayer F, Feyer P, Harms W, Haase W, Dunst J, Wenz F, Sauer R.: DEGRO practical guidelines for radiotherapy of breast cancer II. Postmastectomy radiotherapy, irradiation of regional lymphatics, and treatment of locally advanced disease. Radiation Oncol 2008;184:347-53.
  • Krempien R, Hoppe H, Kahrs L, Daeuber S, Schorr O, Eggers G, Bischof M, Munter MW, Debus J, Harms W.: Projector-Based Augmented Reality for Intuitive Intraoperative Guidance in Image-Guided 3D Interstitial Brachytherapy. Int J Radiat Oncol Biol Phys 2008;70:944-52.
  • Hauswald H, Lindel K, Rochet N, Debus J, Harms W.: Surgery with Complete Resection Improves Survival in Radiooncologically Treated Patients with Cervical Lymph Node Metastases from Cancer of Unknown Primary. Radiation Oncol 2008;184:150-156.
  • Rochet N, Sterzing F, Jensen A, Dinkel J, Herfarth K, Schubert K, Eichbaum M, Schneeweiss A, Sohn C, Debus J, Harms W.: Helical Tomotherapy as a New Treatment Technique for Whole Abdominal Irradiation. Radiation Oncol 2008;184:145-149.
  • Roeder F, Treiber M, Oertel S, Dinkel J, Timke C, Funk A, Garcia-Huttenlocher H, Bischof M, Weitz J, Harms W, Hensley FW, Buchler MW, Debus J, Krempien R.: Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2007;67:1381-8.
  • Sauer R, Sautter-Bihl ML, Budach W, Feyer P, Harms W, Souchan R, Wallwiener D, Kreienberg R, Wenz F.: Accelerated partial breast irradiation: consensus statement of 3 German Oncology societies. Cancer 2007;110:1187-94.
  • Schöffel PJ, Harms W, Sroka-Perez G, Schlegel W, Karger CP.: Accuracy of a commercial optical 3D surface imaging system for realignment of patients for radiotherapy of the thorax. Phys Med Biol 2007;52:3949-63.
  • Sterzing F, Grehn C, Dinkel J, Krempien R, Hartung G, Debus J, Harms W.: Severe reversible toxic encephalopathy induced by cisplatin in a patient with cervical carcinoma receiving combined radiochemotherapy. Radiation Oncol 2007;183:487-9.
  • Sautter-Bihl ML, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sedlmayer F, Souchon R, Wenz F, Sauer R.: DEGRO Practical Guidelines for Radiotherapy of Breast Cancer I: Breast-Conserving Therapy. Radiation Oncol. 2007;183:661-6.
  • Rochet N, Jensen AD, Sterzing F, Munter MW, Eichbaum MH, Schneeweiss A, Sohn C, Debus J, Harms W.: Adjuvant whole abdominal intensity modulated radiotherapy (IMRT) for high risk stage FIGO III patients with ovarian cancer (OVAR-IMRT-01) - Pilot trial of a phase I/II study: study protocol. BMC Cancer 2007;7:227.
  • Harms W.: Radiotherapy in old age. Geriatrics Practice 2007;4:8-12.
  • Eichbaum M, Harms W, Bolz S, Schneeweiss A, Sohn C.: Generalised lichen ruber planus with oral manifestation - induced by radiotherapy of the breast? Oncology 2006;29:521-3.
  • Krempien R, Münter MW, Harms W, Debus J.: Neoadjuvant chemoradiation in patients with pancreatic adenocarcinoma. HPB 2006;8:22-28.
  • Guidelines in Radiation Oncology, Radiotherapy of Breast Cancer, Coordinator R. Sauer, DEGRO Organ Group Breast Cancer, Expert Group: Budach W, Dunst J, Feyer P, Haase W, Harms W, Sautter-Bihl ML, Souchon R, Wenz F, Strahlenther Onkol 2006;182:Supplemet I, page 1-29.
  • Harms W, Krempien R, Grehn C, Hensley F, Debus J, Becker HD: Electromagnetically navigated brachytherapy as a new treatment option for peripheral pulmonary tumours. Radiation Oncol 2006;182:108-11.
  • Krempien RC, Röder F, Oertel S, Weitz J, Hensley FW, Timke C, Funk A, Lindel K, Harms W, Buchler MW, Debus J, Treiber M.: Intraoperative Electron Beam Therapy (IOERT) for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2006;65:773-9.
  • Harms W, Weber KJ, Ehemann V, Zuna I, Debus J, Peschke P.: Differential effects of CLDR and PDR brachytherapy on cell cycle progression in a syngeneic rat prostate tumour model. Int J Radiat Biol 2006;82:191-6.
  • Eichbaum M, Schneeweiss A, Harms W, Schemmer P, Sohn C.: Ileouterine fistula: a rare complication after primary treatment of advanced endometrial cancer. Lancet Oncology 2006;7:442.
  • Souchon R, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sautter Bihl M-L, Wenz F, Sauer R.: Radiotherapy after breast-conserving surgery for ductal carcinoma in situ (DCIS) must not be dispensed with. Strahlenther Onkol 2006;182:429-30.
  • Krempien R, Niethammer A, Harms W, Debus J.: Use of bisphosphonates for bone metastases. Expert Rev Anticancer Ther
  • Harms W, Krempien R, Grehn C, Schneeweiß A, Sohn C, Debus J.: Radiotherapy of locoregional breast carcinoma recurrences. JournalOncology 2005;1:14-16.
  • Ryschich E, Jesnowski R, Ringel J, Harms W, Fabian OV, Saller R, Schrewe M, Engel A, Schmidt J, Lohr M.: Combined therapy of experimental pancreatic cancer with CYP2B1 producing cells: low-dose ifosfamide and local tumour irradiation. Int J Cancer 2005;113:649-53.
  • Maksan SM, Schmidt E, Ryschich E, Harms W, Schmidt J.: Enhancement of leukocyte adhesion after percutaneous irradiation in rats with hepatocellular carcinoma. World J Gastroenterol
  • Krempien R, Grehn C, Haag C, Straulino A, Hensley FW, Kotrikova B, Hofele C, Debus J, Harms W.: Feasibility report for retreatment of locally recurrent head and neck cancer by combined brachy-chemotherapy using frameless image guided 3D interstitial brachytherapy. Brachytherapy 2005;4:154-62.
  • Harms W, Krempien R, Grehn C, Berns C, Hensley FW, Debus J.: Daytime pulsed dose rate brachytherapy as a new treatment option for previously irradiated patients with recurrent oesophageal cancer. British J Radiol 2005;78:236-41.
  • Dietz A, Rudat V, Harms W, Jungehülsing M, Dollner R, Henze M.: Diagnostics using 18F-FDG-PET after laryngeal organ preservation by primary radiochemotherapy. HNO 2004;52:38-44.
  • Krempien R, Heinemann V, Münter M, Harms W, Debus J.: Multimodal curative/neoadjuvant therapy for pancreatic carcinoma. Oncologist 2004;10:1301-9.
  • Krempien R, Hassfeld S, Kozak J, Tuemmler HP, Däuber S, Treiber M, Debus J, Harms W.: Frameless image guidance improves accuracy in three dimensional interstitial brachytherapy needle placement. Int J Radiat Oncol Biol Phys 2004;60:1645-51.
  • Harms W, Krempien R, Grehn C, Hensley F, Berns C, Wannenmacher M.: Debus J. Reirradiation of the thoracic wall in locally recurrent breast carcinomas. Zentralbl Gynäkol 2004;126:19-23.
  • Ryschich E, Schmidt J, Loeffler T, Gebhard M, Harms W, Klar E.: Different radiogenic effects on microcirculation in healthy pancreas and in pancreatic carcinoma of the rat. Ann Surg 2003;237:515-21.
  • Ryschich E, Harms W, Loeffler T, Eble M, Klar E, Schmidt J.: Radiation-induced leukocyte adhesion to endothelium in normal pancreas and in pancreatic carcinoma of the rat. Int J Cancer 2003;105:506-11.
  • Krempien R, Huber P, Harms W, Treiber M, Wannenmacher W, Krempien B.: Combination of early bisphosphonate administration and irradiation enables improved remineralisation and restabilization of osteolytic bone metastases in an animal tumor model. Cancer 2003;98:1318-24.
  • Krempien R, Daeuber S, Hensley FW, Wannenmacher M, Harms W.: Image fusion of CT and MRI data enables improved target volume definition in 3D-brachytherapy treatment planning. Brachytherapy 2003;2(3):164-71.
  • Kayhan N, Krempien R, Harms W, Wannenmacher M, Hagl S, Vahl CF: Computer-assisted reconstruction of coronary arteries. Biomed Tech 47 Suppl 1 Pt 2002;2:930-2.
  • Krempien RC, Schubert K, Zierhut D, Steckner MC, Treiber M, Harms W, Mende U, Latz D, Wannenmacher M, Wenz F.: Open low-field magnetic resonance imaging in radiation therapy treatment planning. Int J Radiat Oncol Biol Phys 2002;53:1350-60.
  • Gagel B, Schramm O, Harms W, Mulhern A, Wenz F, van Kampen M, Wannenmacher M, Eble MJ.: The electronic portal imaging system Siemens Beamview Plus versus the conventional verifications films CEA-TVS and DuPont COL-7. A critical appraisal of visual image quality. Strahlenther Onkol 2002;178:446-52.
  • Harms W, Peschke P, Weber KJ, Hensley FW, Wolber G, Debus J, Wannenmacher M.: Dose-dependent differential effects of low and pulsed dose-rate brachytherapy in a radioresistant syngeneic rat prostate tumour model. Int J Radiat Biol 2002;78:617-23.
  • Thilmann C, Zabel A, Nill S, Rhein B, Hoess A, Haering P, Milker-Zabel S, Harms W, Schlegel W, Wannenmacher M, Debus J.: Intensity-modulated radiotherapy of the female breast. Med Dosim 2002;27:79-90.
  • Schulz-Ertner D, Zierhut D, Mende U, Harms W, Branitzki P, Wannenmacher M.: The role of radiation therapy in the management of desmoid tumours. Radiation Oncol 2002;178:78-83.
  • Krempien R, Daeuber S, Hoppe H, Treiber M, Harms W, Raczkowsky J, Brief J, Debus J, Woern H, Wannenmacher M.: Daily patient set-up control in radiation therapy by coded light projection. Stud Health Technol Inform 2002;85:237-239.
  • Ryschich E, Schmidt J, Loeffler T, Gebhard M, Harms W, Klar E.: Different effects of radiotherapy in healthy pancreas and pancreatic carcinoma in rats. Surgical Forum 2002;31:227-9.
  • Harms W, Krempien R, Hensley FW, Berns C, Fritz P, Wannenmacher M.: 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer. Radiation Oncol 2002;178:607-14.
  • Harms W, Becker HD, Krempien R, Wannenmacher M.: Contemporary role of modern brachytherapy techniques in the management of malignant thoracic tumours. Semin Surg Oncol 2001;20:57-65.
  • Harms W, Krempien R, Hensley FW, Berns C, Wannenmacher M, Fritz P.: Results of chest wall reirradiation using pulsed-dose-rate (PDR) brachytherapy moulds for breast cancer local recurrences. Int J Radiat Oncol Biol Phys 2001;49:205-10.
  • Harms W, Latz D, Becker H, Gagel B, Herth F, Wannenmacher M.: Treatment of primary tracheal carcinoma. The role of external and endoluminal radiotherapy. Strahlenther Onkol 2000;176:22-7.
  • Harms W, Schraube P, Becker H, Latz D, Herth F, Fritz P, Wannenmacher M.: Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumours of the upper respiratory tract. Radiation Oncol 2000;176:60-6.
  • Fritz P, Hensley FW, Berns C, Harms W, Wannenmacher M.: Long-term results of pulsed irradiation of skin metastases from breast cancer. Effectiveness and sequelae. Radiation Oncol 2000;176:368-76.
  • Krempien R, Grabowski HA, Harms W, Hensley FW, Hassfeld S, Mende U, Treiber M, Wannenmacher M. :Synthetic image modalities generated from matched CT and MRI data: A new approach for using MRI in brachytherapy. Lecture Notes in Computer Science 1999;1679:963-72.
  • Harms W, Latz D, Becker H, Herth F, Schraube P, Krempien R, Wannenmacher M.: HDR-brachytherapy boost for residual tumour after external beam radiotherapy in patients with tracheal malignancies. Radiother Oncol 1999;52:251-5.
  • Schwarz S, Schwab S, Harms W, Hacke W.: Systemic lymphoma in patients with the initial diagnosis of primary central nervous system lymphoma: a report of two cases. J Neurol

      • Book contributions

      • Harms W.: Pulse dose rate (PDR) brachytherapy - Experimental and clinical studies on effectiveness and toxicity. In: Radiation Protection in Research and Practice Volume 48/49, Editors Pirich C, Wolf H, Reiners Ch, German Society for Medical Radiation Protection, p.23-25,2007.
      • Harms W, Weber K.: Biological Aspects: Total dose and fractionation In: Partial breast irradiation with multicatheter brachytherapy, Eds: Strnad, Ott; 2006.
      • Freund U, Harms W.: Mammakarzinom, In: Facharztbuch Strahlentherapie, Eds: Wannenmacher M, Debus J, Wenz F; Springer-Verlag, Berlin-Heidelberg-New-York,S.451-82,2006.
      • Bahnsen J, Hänsgen G, Harms W, Ladner HA: Female Pelvis, In: Facharztbuch Strahlentherapie, Eds: Wannenmacher M, Debus J, Wenz F; Springer-Verlag, Berlin-Heidelberg-New-York,pp.623-56;2006.
      • Krempien R, Daeuber S, Hoppe H, Schorr O, Wannenmacher M, Harms W. Projector-based augmented reality in interstitial brachytherapy. Informatik Aktuell 2003.
      • Friess H, Haberkorn U, Harms W, Nawroth P, Raue F, Post S, Schilling T, Weber T, Wannenmacher M, Otto HF.: Publication series of the Tumour Centre Heidelberg/Mannheim: Thyroid Carcinoma. Recommendations for standardised diagnosis, therapy and aftercare. 3rd completely revised edition 2003.
      • Becker HD, Harms W, Herth F.: Photodynamic therapy. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,p.303-307,2003.
      • Harms W, Herth F, Becker HD: Options and results of endobronchial brachytherapy. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,p.299-303,2003.
      • Debus J, Lohr F, Harms W.: Radiotherapy. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,p.259-267,2003.
      • Becker HD, Harms W, Herth F.: Options and results of endobronchial therapy. In: Management des Lungenkarzinoms, Eds: Drings P, Wannenmacher M; Springer-Verlag, Berlin-Heidelberg-New York,p.286-298,2003.
      • Krempien R, Daeuber S, Hoppe H, Treiber M, Debus J, Harms W, Brief J, Raczkowsky J, Wörn H, Wannenmacher W.: Daily patient set-up in radiation therapy by structural light projection. In: H.U. Lemke, M.W. Vannier, K. Inamura, A.G. Farman (eds.): Proceedings of the 15th International Congress and Exhibition on Computer Assisted Radiology and Surgery (CARS 2001), Berlin, Elsevier Press,p.1094,2001.
      • Krempien R, Grabowski HA, Harms W, Daeuber S, Hensley FW, Pernozzoli A, Brief J, Treiber M, Wannenmacher M.: Image fusion in radiotherapy. In: W. Schlegel, T. Bortfeld (eds.): The use of computers in radiation therapy. Proceedings of XIIIth ICCR, Heidelberg, May 22-25, Springer-Verlag, Berlin-Heidelberg-New-York,pp.93-95,2000.
      • Fritz P, Hensley FW, Berns C, Harms W, Wannenmacher M.: Pulsed irradiation of the human skin (effectiveness and sequelae). In Proceedings of the German Brachytherapy Conference 05-07 March 1997 Lübeck. Eds: E. Richter, T. Feyerabend, M. Marx;p.200,1997.